LT treatment markedly enhanced CAT activities in cardiac (P < 0.05 and P < 0.01; respectively), hepatic (P < 0.05 and P < 0.01; respectively) and renal (P < 0.05 and P < 0.01; respectively) tissues as compared to HCD group. Here, CAT is linked to heavy chain disease.